通用中文 | 阿瑞匹坦胶囊 | 通用外文 | Aprepitant Capsules |
品牌中文 | 意美 | 品牌外文 | Emend |
其他名称 | |||
公司 | 默克(Merck) | 产地 | 美国(USA) |
含量 | 125mg+80mg | 包装 | 3粒/盒 |
剂型给药 | 储存 | 室温 | |
适用范围 | 化疗呕吐 |
通用中文 | 阿瑞匹坦胶囊 |
通用外文 | Aprepitant Capsules |
品牌中文 | 意美 |
品牌外文 | Emend |
其他名称 | |
公司 | 默克(Merck) |
产地 | 美国(USA) |
含量 | 125mg+80mg |
包装 | 3粒/盒 |
剂型给药 | |
储存 | 室温 |
适用范围 | 化疗呕吐 |
中文药名:阿瑞吡坦胶囊
药品介绍
【通用名称】阿瑞匹坦胶囊
【英文名称】Aprepitant Capsules
【主要成分】阿瑞匹坦
【适 应 症】化疗呕吐
【用法用量】:Emend为口服胶囊剂,临床上用于与其它止吐药联合用药。连续三天,每日一次剂量,推荐剂量为化疗前1小时,口服125mg,第二,三天清晨各80mg,无论与食物是否同服均可。
【规 格】注:以下产品不同规格和不同价格,购买以咨询为准
(1)阿瑞匹坦胶囊125毫克:3粒(PTP),6粒(PTP)
(2)阿瑞匹坦胶囊80毫克:6粒(PTP),30粒(PTP)
(3)阿瑞匹坦组合胶囊(125毫克胶囊×1,80mg胶囊×2)/张
【包装】铝塑板包装。
【贮藏】30℃以下原包装保存。
【生产商】小野薬品工業株式会社
Emend (aprepitant) is a neurokinin-1 (NK1)-receptor antagonist. It stops a chemical in the body (substance P) from binding to the NK1 receptors. When substance P attaches to these receptors, it causes nausea and vomiting. By blocking the receptors, Emend can prevent nausea and vomiting, which often happens after chemotherapy or as a complication of surgery.
注:本品原处方附件:http://www.info.pmda.go.jp/go/pack/2391008M1021_1_05/
【阿瑞匹坦产品特点】
阿瑞吡坦(aprepitanl)及福沙吡坦(fosapitant)是目前上市用于止吐的NK.1受体拮抗剂。阿瑞吡坦的前体药物静脉用福沙吡坦二甲葡 胺注射液。NK-1受体是速激肽(NKA)P物质(SP)的结合位点,位于脑干呕吐中枢和胃肠道。动物试验证明SP能诱发呕吐.而特异性阻断该受体的药物 能预防所有致吐刺激物(包括顺铂)导致的呕吐。
多项临床研究证明,包含阿瑞吡坦的止吐方案在预防高、中致吐风险药物(尤其以顺铂为主的化疗药物)导致的急性和迟发性CINV时疗效更佳,而且不加重不良 反应。阿瑞吡坦还是细胞色素P450(CYP)3A4的中度抑制剂。理论上由于某些止吐药(如糖皮质激素)和化疗药(如环磷酰胺和多西他赛)为 CYP3A4的底物,当其与阿瑞吡坦联用时代谢会受到影响。因此,当联用糖皮质激素和阿瑞吡坦时前者的剂量应减低。但这并不适用于接受含糖皮质激素化疗方 案者。目前临床上也未见标准用法及用量的阿瑞吡坦与上述化疗药合用导致临床后遗症的任何证据。新指南建议,目前只按已确定的阿瑞吡坦的剂量和方案用药。
对急性CINV的预防,接受高致吐风险药物化疗者以及接受蒽环类药物和环磷酰胺联合化疗的患者推荐5-HT3受体阻断剂、地塞米松和阿瑞吡坦(一次 125mg)联用。对所有接受顺铂和其他高致吐风险药物化疗的患者,推荐应用地塞米松和阿瑞吡坦(一次80mg×2日)二
联药物预防迟发性CINV,不再 推荐5-HT。受体阻断剂和地塞米松二药联合。对于接受蒽环类药物和环磷酰胺联合化疗的患者,推荐应用阿瑞吡坦单药治疗。
aprepitant
Generic Name: aprepitant (a PREP i tant)
Brand Name: Emend, Emend 2-Day, Emend 3-Day
What is aprepitant?
Aprepitant blocks the actions of chemicals in the body that trigger nausea and vomiting.
Aprepitant is used in adults and children to prevent nausea and vomiting caused by cancer chemotherapy. Aprepitant is also used (only in adults) to prevent nausea and vomiting that may be caused by surgery.
Aprepitant is given ahead of time and will not treat nausea or vomiting that you already have.
Aprepitant capsules are for use in adults and children who are at least 12 years old. Aprepitant oral suspension (liquid) can be given to adults and children as young as 6 months old.
Aprepitant may also be used for purposes not listed in this medication guide.
Important Information
You should not take aprepitant if you also take pimozide. A serious drug interaction can occur when pimozide is used together with aprepitant.
Before taking this medicine
You should not use aprepitant if you are allergic to it, or if you take another medicine called pimozide (Orap). Aprepitant can cause unwanted or dangerous effects when used with pimozide.
To make sure aprepitant is safe for you, tell your doctor if you have:
It is not known whether this medicine will harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant.
Aprepitant can make birth control pills less effective. Ask your doctor about using a non-hormonal birth control (condom, diaphragm with spermicide) to prevent pregnancy, and for 1 month after your last dose.
It is not known whether aprepitant passes into breast milk or if it could harm a nursing baby. Tell your doctor if you are breast-feeding a baby.
How should I take aprepitant?
Follow all directions on your prescription label. Do not take this medicine in larger or smaller amounts or for longer than recommended.
Aprepitant is not for long-term use. For use in chemotherapy, you will most likely need only 3 separate doses. When used before surgery, you will likely receive only 1 dose.
The first dose of aprepitant is usually taken 1 hour before treatment with chemotherapy, or 3 hours before a surgery. Follow your doctor's dosing instructions very carefully.
You may also be given other medicines with aprepitant to further help prevent nausea and vomiting.
Read all patient information, medication guides, and instruction sheets provided to you. Ask your doctor or pharmacist if you have any questions.
Aprepitant can be taken with or without food. If you take aprepitant before surgery, follow your doctor's instructions about any restrictions on food or beverages.
Do not crush, chew, break, or open an aprepitant capsule. Swallow it whole.
Give the oral suspension (liquid) using only the dosing syringe provided.
Do not share this medicine with another person. Aprepitant should not be used to treat general nausea that is unrelated to chemotherapy or surgery.
If you also take warfarin (Coumadin, Jantoven), you may need extra "INR" or prothrombin time tests after you have taken aprepitant.
Store aprepitant capsules at room temperature away from moisture and heat.
Store the prefilled liquid dosing syringe in the refrigerator, do not freeze. After taking the liquid out of the refrigerator, you must use it within 3 hours.
Throw away any liquid medicine not used within 3 days (72 hours) after you received it. Do not save it for later use.
What happens if I miss a dose?
Call your doctor for instructions if you forget to take your medicine within the prescribed length of time before your chemotherapy or surgery.
What happens if I overdose?
Seek emergency medical attention or call the Poison Help line at 1-800-222-1222.
What should I avoid while taking aprepitant?
Follow your doctor's instructions about any restrictions on food, beverages, or activity.
Aprepitant side effects
Get emergency medical help if you have signs of an allergic reaction: hives, rash, itching, skin sores or peeling; warmth or tingly feeling; trouble breathing or swallowing; swelling of your face, lips, tongue, or throat.
Call your doctor at once if you have:
· a light-headed feeling, like you might pass out;
· low blood cell counts--fever, chills, flu-like symptoms, swollen gums, mouth sores, skin sores, rapid heart rate, pale skin, easy bruising, unusual bleeding; or
· dehydration symptoms--feeling very thirsty or hot, being unable to urinate, heavy sweating, or hot and dry skin.
Common side effects may include:
· stomach pain, indigestion, loss of appetite;
· diarrhea, constipation;
· hiccups;
· abnormal liver function tests;
· cough; or
· feeling weak or tired.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
See also: Side effects (in more detail)
Aprepitant dosing information
Usual Adult Dose for Nausea/Vomiting -- Chemotherapy Induced:
MODERATELY TO HIGHLY EMETOGENIC CANCER CHEMOTHERAPY (HEC/MEC):
Oral Capsules:
-Day 1: 125 mg orally once 1 hour before chemotherapy
-Days 2 and 3: 80 mg orally once a day, 1 hour before chemotherapy OR in the morning (if chemotherapy is not given on Days 2 and 3)
-Duration of therapy: 3 days/cycle
Oral Suspension:
-Day 1: 3 mg/kg orally once 1 hour before chemotherapy
---Maximum dose: 125 mg/dose
-Days 2 to 3: 2 mg/kg orally once a day, 1 hour before chemotherapy OR in the morning (if chemotherapy is not given on Days 2 and 3)
---Maximum dose: 80 mg/dose
-Duration of therapy: 3 days/cycle
Comments:
-The recommended dosage of dexamethasone is 12 mg orally on Day 1 administered 30 minutes prior to chemotherapy and 8 mg orally in the mornings on Days 2 through 4 (HEC) or Days 2 through 3 (MEC).
-The 5-HT3 antagonist is administered on Day 1 only. Consult the package insert for the 5-HT3 antagonist dosing prior to initiation of treatment.
-This drug may be taken with or without food.
Uses:
-In combination with other antiemetic agents for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of HEC including high-dose cisplatin
-In combination with other antiemetic agents for the prevention of nausea and vomiting associated with initial and repeat courses of MEC
Usual Adult Dose for Nausea/Vomiting -- Postoperative:
40 mg orally once within 3 hours prior to induction of anesthesia
Use: Prevention of nausea and vomiting
Usual Pediatric Dose for Nausea/Vomiting -- Chemotherapy Induced:
12 years and older:
MEC/HEC:
Oral Capsules:
-Day 1: 125 mg orally once 1 hour before chemotherapy
-Days 2 and 3: 80 mg orally once a day, 1 hour before chemotherapy OR in the morning (if chemotherapy is not given on Days 2 and 3)
-Duration of therapy: 3 days/cycle
Oral Suspension:
-Day 1: 3 mg/kg orally once 1 hour before chemotherapy
---Maximum dose: 125 mg/dose
-Days 2 to 3: 2 mg/kg orally once a day, 1 hour before chemotherapy OR in the morning (if chemotherapy is not given on Days 2 and 3)
---Maximum dose: 80 mg/dose
-Duration of therapy: 3 days/cycle
Comments:
-If a corticosteroid (e.g., dexamethasone) is coadministered, patients should be given 50% of the recommended pediatric dose on Days 1 to 4. Consult the package insert for the corticosteroid dosing prior to initiation of treatment.
-The 5-HT3 antagonist is administered on Day 1 only. Consult the package insert for the 5-HT3 antagonist dosing prior to initiation of treatment.
-This drug may be taken with or without food.
Uses:
-In combination with other antiemetic agents for the prevention of acute and delayed nausea and vomiting associated with initial and repeat courses of HEC including high-dose cisplatin
-In combination with other antiemetic agents for the prevention of nausea and vomiting associated with initial and repeat courses of MEC
What other drugs will affect aprepitant?
Sometimes it is not safe to use certain medications at the same time. Some drugs can affect your blood levels of other drugs you take, which may increase side effects or make the medications less effective.
Many drugs can interact with aprepitant. This includes prescription and over-the-counter medicines, vitamins, and herbal products. Not all possible interactions are listed in this medication guide. Tell your doctor about all your current medicines and any medicine you start or stop using.